|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
Thank You for Attending the 2015 AAPS Career Fair!
Thank you to those who were able to attend the AAPS Annual Meeting & Exposition in Orlando and stopped by the AAPS Career Fair. We had a very productive two days! In fact, with the pre-conference alert system, AAPSCareers Live, in place again this year, the participating employers were able to set up quite a few interviews prior to the fair. This new alert system also offered our candidates the opportunity to post and flag their résumé, so all participating employers posting a position on our Career Center had the opportunity to search candidate résumés prior to the Annual Meeting.
We also provided a variety of mini-sessions inside our Career Fair with timely topics including: Identifying and Applying your Differentiated Strengths, Understanding the Power of Self-Assessment, Effective Communication and many more.
We also want to thank our 2015 AAPS Career Fair Employer Participants for making this year’s Career Fair a great success: Adare Pharmaceuticals, Inc., Amway, Catalent Pharma Solutions, DPT, Eli Lilly, Upsher-Smith, Teva, Food and Drug Administration, Chapman University, GlxoSmithKline, Perrigo, West-Ward Pharmaceuticals, Noven Pharmaceuticals, Celgene Corporation, UPM Pharmaceuticals, Johns Hopkins University, Mylan Pharmaceuticals, Akorn, University of Texas at El Paso, Lupin, Inc., Dr. Reddy’s Laboratories, Sancilio and Company, and KenPharm, Inc.
Four Generations in the Workplace: New Challenges
Today it is not uncommon to find four generations working together:
What are the issues for hiring managers, company leaders, and coworkers? In a review of resources on this topic, AAPS found the following recommendations.
- Silents (Born between 1925 and 1946)
- Baby Boomers (Born between 1946 and 1964)
- Generation Xers (Born between 1965 and 1980)
- Generation Ys or Millennials (born after 1980)
Read more on the Career Success webpage of the AAPS Career Center.
For a complete list of job postings, click here.
Have a job to post? Click here.
PHARMACEUTICAL CAREER NEWS
FDA Overhauls Inspection Operations
After two years of planning and analysis, FDA officials are moving forward with implementation of the Program Alignment plan to better coordinate agency field inspections with product reviews from FDA research centers. The aim is to reduce redundant processes and to provide more expertise in evaluating today’s more complex and varied production systems for drugs and biologics.
The TPP Text Has Been Released — Where Does Canada Go From Here?
By Katherine Radin
This fall, the Trans-Pacific Partnership (TPP) was signed by 12 Pacific Rim countries, creating a global trading block that represented about 40 percent of the world's domestic product. At the time the TPP was announced, Canada's then-prime minster, Stephen Harper, stated that the document would be made available following the Canadian federal election.
Passion: Your Secret Weapon For Job Search Success
Think about what lies at the root of your interest in a science career. Why did you get into science in the first place — you know, back in your early days? Was it the promise of a big-time salary? Probably not. Science careers have never been touted as a sure-fire way to earn big-time compensation, and salary rarely comes up as a top selection factor for students deciding their future careers. Was it the prestige of an academic appointment at a distinguished university? I doubt it.
'60 Minutes' Blames The Pharmaceutical Industry For America's Heroin Epidemic
60 Minutes correspondent Bill Whitaker went to Columbus, Ohio, to understand America’s heroin epidemic. The drug is becoming cheaper and easier to get, he argues, and its stigma is vanishing. But his reporting places much of the blame for the addictions and deaths he documents on opioid pain pills. People become addicted to the pills, and than switch to heroin because it is cheaper.
Top Firms Prioritize Transformative Technologies, Patients
The biotechnology and pharmaceutical sectors have emerged from the global recession to find technological breakthroughs driving renewed enthusiasm and risk-taking at companies. The firms landing at the top of the 2015 Science Careers Top Employers Survey have harnessed these innovative sparks and created workplaces that recruit the best and brightest scientific minds.
Tough Pill To Swallow: Senate To Probe Price Gouging On Prescription Drugs
The Senate announced a bipartisan investigation into potential price gouging on prescription drugs after a speculator bought the patent for an AIDS treatment and announced he was hiking the price more than 5000 percent.
“Some of the recent actions we’ve seen in the pharmaceutical industry — with corporate acquisitions followed by dramatic increases in the prices of pre-existing drugs — have looked like little more than price gouging,” said Sen. Claire McCaskill, Missouri Democrat.
Are You Running To a New Job — Or From Your Current One?
By Hank Boyer
If you are contemplating making a job change, it's time to ask yourself the hard question: How much of your motivation is running to a new opportunity, versus running from your present situation?
There are some days that every employee dreads strapping on the uniform and going to work. And there are some jobs that downright sap the joy out of working.
Divergence In The Drug Businesses: Pharmaceuticals And Biotechnology
To understand the drug business, Aswath Damodaran went back to 1991, towards the beginning of a surge in spending in the US on health care. The pharmaceutical companies at the time were cash machines, built on a platform of substantial up front investments in research and development. The drugs generated by R&D that made it through FDA approval and into commercial production were used to cover the aggregated cost of R&D and to generate significant excess profits.
Changing the Prescription Drugs Pricing Game
One of the hottest issues this year in the health care world has been the costs of pharmaceuticals. From the firestorm around the spike in cost of Daraprim, to politicians wading into the fray, calls for decreases in the price of cancer drugs and an increasing movement towards value pricing; how drug prices are set will be a major issue in the next few years with huge effects on the industry, and of course, on pharmaceutical sales representatives.
AAPS Career Services
Colby Horton, Vice President of Publishing, MultiBriefs, 469.420.2601
Download media kit
Jessica Taylor, Medical Editor, MultiBriefs, 202.684.7169
Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.
This edition of the AAPS Pharmaceutical Career News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Oct. 9, 2015
Sept. 11, 2015
Aug. 28, 2015
Aug. 14, 2015
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063